251 Air Force General Hospital
- Address
- lock Available on a paid plan
Dermatological Research at 251 Air Force General Hospital
The Dermatology Department at 251 Air Force General Hospital in Athens conducts clinical research focused on skin conditions and dermatological disorders. This healthcare facility contributes to advancing understanding and treatment approaches for various skin-related diseases through systematic clinical investigation.
- Evaluation of therapeutic interventions for dermatological conditions
- Assessment of treatment effectiveness in skin disease management
- Investigation of novel approaches to dermatological care
The research activities at this site reflect a commitment to improving patient outcomes in dermatology, with studies designed to enhance clinical practice and contribute valuable data to the broader medical community. The department's work supports the development of evidence-based treatment strategies for patients experiencing various skin disorders.
Clinical Investigation in Skin Health
Research conducted at this Athens-based military hospital focuses on addressing dermatological health challenges through clinical trials. The Dermatology Department engages in studies that evaluate both existing and emerging therapeutic options for patients with skin conditions, contributing to the advancement of dermatological medicine.
- Clinical assessment of dermatological treatment modalities
- Research into skin disease pathophysiology and management
- Patient-centered studies in dermatological care
The facility's research portfolio demonstrates dedication to improving the quality of care for individuals affected by skin disorders. Through systematic clinical investigation, the department works to identify effective treatment strategies and optimize therapeutic outcomes for patients requiring dermatological intervention.
Advancing Dermatology Through Clinical Research
The clinical trial activities at 251 Air Force General Hospital represent focused efforts in the field of dermatology. Research initiatives are designed to evaluate treatment approaches for various skin conditions, with the goal of enhancing therapeutic effectiveness and patient well-being.
- Studies targeting specific dermatological disorders
- Evaluation of treatment safety and efficacy in skin diseases
- Research supporting evidence-based dermatological practice
The department's research efforts contribute to the broader understanding of skin pathology and treatment optimization. By conducting clinical trials, the facility plays a role in developing improved care protocols for patients experiencing dermatological conditions, supporting both local and international medical knowledge in this specialized field.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 35 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in 251 Air Force General Hospital
lock Showing 1 of 11 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A PHASE 2 STUDY EVALUATING INCB099280 IN PARTICIPANTS WITH SELECT SOLID TUMORS WHO ARE IMMUNE CHECKPOINT INHIBITOR–NAÏVE | Incyte Corp. | Phase II | Not Recruiting | Nov 2023 | Feb 2026 |
IMP list
lock Showing 1 of 35 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bortezomib | 2 | Unknown | 2020-09-28 | 2024-02-26 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.